Daily Summary
Biden is planning new health care initiatives to lower prescription drug prices and expand the Affordable Care Act, positioning his approach against Trump’s previous proposals. In addition, a new Medicare policy starting in 2025 will cap out-of-pocket prescription costs, potentially saving millions of beneficiaries, while the Supreme Court examines a case over the FDA’s regulation of an abortion pill that could affect future drug approvals. Meanwhile, state lawmakers are gearing up for 2025 by prioritizing legislation on reproductive health, including abortion and contraception policies, in response to recent legal changes.
Biden’s 2024 Turnaround: Major Health Care Overhaul with Drug Price Reforms
President Biden is preparing a sweeping health care reform package aimed at cutting prescription drug prices and expanding the Affordable Care Act as a key part of his 2024 turnaround strategy.
Abortion, Health Workforce Top 2025 State Legislative Priorities
State lawmakers are setting their 2025 legislative priorities on reproductive health reforms and addressing health workforce shortages in response to changes following the 2022 Supreme Court decision on abortion.
Supreme Court Reviews Abortion Pill Case With Wider FDA Implications
The Supreme Court is reviewing a case on the FDA’s regulation of the abortion pill mifepristone. The decision could set a precedent affecting the agency’s broader drug approval processes.
Millions Set to Benefit from 2025 Prescription Drug Cost Cuts
Starting January 2025, a $2,000 out-of-pocket cap for Medicare Part D will help over a million beneficiaries save at least $1,000 annually, according to a new AARP report stemming from the 2022 Inflation Reduction Act.